Company Overview and News
Veristar AIM3D, the ‘software as a solution' for asset integrity, will be deployed on three of MISC's Floating Production Systems (FPS)
Stratasys Ltd. (SSYS - Free Report) is scheduled to report first-quarter 2018 results on May 2. In the trailing four quarters, the company topped earnings estimates thrice, delivering an average beat of approximately 66.97%. Let’s take a look at how things are shaping up prior to this announcement. Factors to Consider Improving customer relationships and deeper market penetration are aiding the financials of Stratasys.
Greetings and welcome to the Brightcove First Quarter 2018 Earnings Call. At this time, all participants are in listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
Dassault Systemes SA ADR (OTCPK:DASTY) Q1 2018 Earnings Conference Call April 25, 2018 9:00 AM ET
Good afternoon and welcome to the First Quarter 2018 HP, Inc. Earnings Conference Call. My name is William and I will be your conference moderator for today's call. We will be facilitating a question-and-answer session towards the end of the conference. As a reminder, this conference is being recorded for replay purposes.
Dassault Systemes has announced the availability of Electro Mobility Accelerator in India at the Auto Expo 2018. The solutions aims to provide industry-proven capabilities to develop new Electric Vehicle ideas, virtually simulate and validate performance, and ensure flexible, lean manufacturing.
Add-in combines conductive and insulating materials in a single 3D print to make complex geometric structures with embedded electronics, encapsulated sensors and antennas
Artificial intelligence is not a zero-sum, winner takes all game. It is an advancement that will result in a wide variety of companies benefitting, a recent JPMorgan report points out. The significant degree of hype surrounding the larger technical categorization of AI has been blistering, but it is justified, the report claims, pointing to spending levels on AI-focused hardware, software and services forecast to increase by more than 5x over by 2021.
LONDON, UK / ACCESSWIRE / November 21, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Exa Corp. (NASDAQ: EXA), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=EXA. Dassault Systèmes announced on November 17, 2017, that its wholly owned subsidiary, 3DS Acquisition 3 Corp.
A new million-dollar training program to help 16 small and medium SA businesses win work on upcoming defence shipbuilding projects will be launched this morning. (WED)
Dassault is acquiring No Magic to bolster its 3DExperience platform for Internet of Things development by small businesses and professionals.
Investors are always looking for stocks that are poised to beat at earnings season and Dassault Systèmes SE (DASTY - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report. That is because Dassault is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
NEW YORK, NY / ACCESSWIRE / October 18, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:
NEW YORK, Oct. 13, 2017 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating Exa Corporation. ("Exa" or the "Company")(NASDAQ: EXA) relating to the sale of the Company to Dassault Systèmes S.E. through a tender offer. As a result of the tender offer, Exa shareholders are only anticipated to receive $14.
This year’s ceremony, the 13th year the Awards have been staged, will be held at The Ivy in Sydney on Thursday October 26.
7h - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
8h - Asif
BUSINESS TrovaGene is a clinical-stage, precision medicine oncology therapeutics company. The company's primary focus is to develop oncology therapeutics for improved cancer care and to optimize drug development by leveraging its proprietary Precision Cancer Monitoring® (“PCM”) technology in tumor genomics. The company's lead drug candidate, PCM-075, is a Polo-like Kinase 1 (“PLK1”) selective adenosine triphosphate (“ATP”) competitive inhibitor. PCM-075 has shown preclinical antitumor activity as a single agent and synergy in combination with more than ten different chemotherapeutics and targeted therapies, such as Zytiga® (abiraterone acetate), Beleodaq® (belinostat), Quizartinib (AC220), a development stage FLT3 inhibitor, and Velcade® (bortezomib) in Acute Myeloid Leukemia (“AML”), metastatic Castration-Resistant Prostate Cancer (“mCRPC”) and other hematologic and solid tumor cancers. On March 15, 2017, the company announced the licensing of PCM-075, a PLK1 inhibitor...
2018-05-19 - Asif
OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...